← Eichor
Condition: Multidrug Resistance Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Multidrug Resistance

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia
Phase N/A · 1 location(s) · University of Namibia · NCT05022238Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT06441006Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bact
Phase 1/Phase 2 · 1 location(s) · University of Rijeka · NCT07106580Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acine
NA · 1 location(s) · Cairo University · NCT07118384Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tube
Phase 3 · 5 location(s) · Huashan Hospital · NCT05081401Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
NA · 1 location(s) · University of California, San Francisco · NCT05553236Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of M
Phase 2 · 11 location(s) · Janssen Research & Development, LLC · NCT02354014Training Protocol on the Natural History of Tuberculosis
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01212003Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract
NA · 2 location(s) · Chuncheon Sacred Heart Hospital · NCT06001333A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bact
NA · 1 location(s) · Henan University of Traditional Chinese Medicine · NCT07206745A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess
Phase N/A · 1 location(s) · Shengjing Hospital · NCT06506318Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs
NA · 1 location(s) · University Hospital, Caen · NCT05872152Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
NA · 5 location(s) · Johns Hopkins University · NCT05671718Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05534750Comprehensive Intervention to Improve Environmental Disinfection
NA · 1 location(s) · Assaf-Harofeh Medical Center · NCT05973916Blinatumomab for CNI-Resistant/Intolerant SRNS in Children
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06607991An Adaptive Randomized Controlled Trial
NA · 1 location(s) · Columbia University · NCT05633056Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06652126Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
Phase 1 · 2 location(s) · Ghady Haidar · NCT07275905Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) Durin
Phase 4 · 1 location(s) · Marco Schiuma · NCT07477119A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Phase 3 · 35 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT07209761Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Phase 3 · 76 location(s) · Basilea Pharmaceutica · NCT06925321Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
NA · 1 location(s) · Albert Einstein College of Medicine · NCT06590428International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06634940A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
Phase 2 · 7 location(s) · WestVac Biopharma Co., Ltd. · NCT07170800A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
Phase 4 · 2 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT05493267Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
Phase 2/Phase 3 · 1 location(s) · Mansoura University · NCT06843668
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.